Trials / Completed
CompletedNCT01473368
Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota
Open Label, Randomized Pilot Study to Examine The Effects of the Probiotic Saccharomyces Boulardii, the Antibiotic Amoxicillin/Clavulanate and the Combination on the Gut Microbiota of Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare and contrast the effects of the probiotic Saccharomyces boulardii, the antibiotic amoxicillin/clavulanate and the combination on the gut microbiota of healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Saccharomyces boulardii | 500 mg, 2 times daily for 14 days |
| DRUG | Amoxicillin Clavulanate | 875/125 mg 2 times daily at least 1 hour before meals for 7 days |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2011-11-17
- Last updated
- 2017-04-04
- Results posted
- 2016-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01473368. Inclusion in this directory is not an endorsement.